RecruitingPHASE1, PHASE2NCT04652908
Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial
Studying OBSOLETE: Cervicothoracic spina bifida aperta
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Davis
- Principal Investigator
- Diana L Farmer, MDUC Davis School of Medicine
- Intervention
- Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix(biological)
- Enrollment
- 55 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2027
Study locations (1)
- UC Davis Health, Sacramento, California, United States
Collaborators
California Institute for Regenerative Medicine (CIRM)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04652908 on ClinicalTrials.govOther trials for OBSOLETE: Cervicothoracic spina bifida aperta
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06802770Evaluation of Depression and Anxiety Levels of Parents of Children with Spina BifidaMarmara University
- ACTIVE NOT RECRUITINGNCT04251806Sleep-disordered Breathing in Infants With MyelomeningoceleUniversity of Michigan
See all trials for OBSOLETE: Cervicothoracic spina bifida aperta →